Stock listing
NASDAQ:HCTI Healthcare Triangle, Inc. Stock
Home listing (NASDAQ) of Healthcare Triangle, Inc.
Follow Healthcare Triangle, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:HCTI
$2.88 USD -0.29 (-9.0%)
Close on Nov 20, 2026
- Day range
- $2.86 – $2.96 USDNov 20, 2026
- Volume
- 7,921 sharesNov 20, 2026
- Market cap
- $2.63M USDAt the close on Nov 20, 2026 · price × 915,189 shares outstanding
- 52-week range
- $2.86 – $3,096.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $203,744 USDMedian day 882 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HCTI · Home | $2.875 USD | -0.285 (-9.0%) | 7,921 | $2.902 | $2.964 | $2.86 | $3.16 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HCTI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.875 | -0.285 | -9.0% | $2.902 | $2.964 | $2.86 | 7,921 | |
| $3.16 | -0.22 | -6.5% | $3.29 | $3.295 | $3.11 | 9,472 | |
| $3.38 | +0.05 | +1.5% | $3.46 | $3.54 | $3.26 | 22,078 | |
| $3.33 | -0.33 | -9.0% | $3.60 | $3.60 | $3.314 | 13,183 | |
| $3.66 | -0.08 | -2.1% | $4.00 | $4.00 | $3.508 | 19,087 | |
| $3.74 | -0.65 | -14.8% | $4.70 | $4.818 | $3.74 | 94,035 | |
| $4.39 | +0.18 | +4.3% | $4.29 | $4.48 | $4.251 | 18,688 | |
| $4.21 | -0.01 | -0.2% | $4.31 | $4.38 | $4.00 | 18,488 | |
| $4.22 | +0.52 | +14.1% | $3.98 | $4.37 | $3.63 | 61,535 | |
| $3.70 | +0.11 | +3.1% | $3.71 | $3.80 | $3.65 | 10,662 | |
| $3.59 | -1.03 | -22.3% | $4.45 | $4.45 | $3.51 | 56,678 | |
| $4.62 | -0.62 | -11.8% | $5.13 | $5.13 | $4.535 | 108,522 | |
| $5.24 | +0.26 | +5.2% | $5.46 | $7.43 | $4.98 | 999,585 | |
| $4.98 | -0.16 | -3.1% | $5.33 | $5.51 | $4.55 | 290,980 | |
| $5.14 | -1.16 | -18.4% | $6.17 | $6.17 | $5.14 | 11,900 | |
| $6.30 | -0.13 | -2.0% | $6.40 | $6.73 | $6.296 | 18,500 | |
| $6.43 | -0.37 | -5.4% | $6.74 | $6.87 | $6.276 | 18,500 | |
| $6.80 | -0.04 | -0.6% | $6.98 | $7.13 | $6.58 | 27,200 | |
| $6.84 | +0.12 | +1.8% | $6.85 | $7.40 | $6.15 | 51,600 | |
| $6.72 | -0.86 | -11.3% | $7.66 | $7.66 | $6.62 | 823 | |
| $7.58 | -0.72 | -8.7% | $7.98 | $8.16 | $7.40 | 678 | |
| $8.30 | +0.42 | +5.3% | $8.30 | $8.34 | $7.86 | 379 | |
| $7.88 | +0.60 | +8.2% | $7.70 | $8.00 | $7.24 | 2,109 | |
| $7.28 | -0.68 | -8.5% | $8.08 | $8.08 | $7.20 | 350 | |
| $7.96 | -0.38 | -4.6% | $8.46 | $8.66 | $7.72 | 254 | |
| $8.34 | +0.70 | +9.2% | $7.42 | $8.36 | $7.42 | 385 | |
| $7.64 | -0.72 | -8.6% | $8.28 | $8.64 | $7.60 | 629 | |
| $8.36 | -0.28 | -3.2% | $8.68 | $8.68 | $8.20 | 460 | |
| $8.64 | -1.02 | -10.6% | $9.66 | $9.88 | $8.28 | 667 | |
| $9.66 | -0.44 | -4.4% | $10.04 | $10.20 | $9.10 | 688 | |
| $10.10 | -1.18 | -10.5% | $11.16 | $11.16 | $10.10 | 584 | |
| $11.28 | +0.16 | +1.4% | $10.78 | $11.74 | $10.00 | 711 | |
| $11.12 | -1.02 | -8.4% | $11.90 | $11.90 | $11.06 | 882 | |
| $12.14 | -2.36 | -16.3% | $12.00 | $12.14 | $11.60 | 2,312 | |
| $14.50 | +0.46 | +3.3% | $14.70 | $14.70 | $13.80 | 1,862 | |
| $14.04 | -0.32 | -2.2% | $14.00 | $14.44 | $13.62 | 2,155 | |
| $14.36 | +1.12 | +8.5% | $13.12 | $18.60 | $13.00 | 61,871 | |
| $13.24 | -1.76 | -11.7% | $14.58 | $14.96 | $13.14 | 1,543 | |
| $15.00 | -0.56 | -3.6% | $15.00 | $15.80 | $14.20 | 1,183 | |
| $15.56 | +0.96 | +6.6% | $14.96 | $15.80 | $14.06 | 3,190 | |
| $14.60 | -3.62 | -19.9% | $15.78 | $15.80 | $13.00 | 6,729 | |
| $18.22 | +0.92 | +5.3% | $22.20 | $63.00 | $17.80 | 136,039 | |
| $17.30 | +1.70 | +10.9% | $15.90 | $17.40 | $15.60 | 371 | |
| $15.60 | +0.10 | +0.6% | $15.52 | $16.90 | $15.40 | 370 | |
| $15.50 | +1.30 | +9.2% | $14.58 | $16.00 | $14.40 | 869 | |
| $14.20 | +0.40 | +2.9% | $14.60 | $15.00 | $13.60 | 287 | |
| $13.80 | -0.40 | -2.8% | $14.40 | $14.74 | $13.64 | 225 | |
| $14.20 | -0.66 | -4.4% | $15.38 | $15.38 | $14.20 | 129 | |
| $14.86 | -0.06 | -0.4% | $14.66 | $15.40 | $14.40 | 102 | |
| $14.92 | +0.04 | +0.3% | $15.30 | $15.54 | $14.80 | 131 | |
| $14.88 | -0.12 | -0.8% | $15.00 | $15.60 | $14.50 | 180 | |
| $15.00 | -0.76 | -4.8% | $16.14 | $16.14 | $14.50 | 497 | |
| $15.76 | -0.06 | -0.4% | $16.02 | $16.02 | $15.40 | 474 | |
| $15.82 | -1.34 | -7.8% | $17.34 | $17.34 | $15.42 | 1,036 | |
| $17.16 | +0.76 | +4.6% | $17.88 | $20.20 | $16.80 | 5,670 | |
| $16.40 | +0.20 | +1.2% | $16.50 | $16.66 | $16.16 | 124 | |
| $16.20 | -0.30 | -1.8% | $16.46 | $16.80 | $16.02 | 348 | |
| $16.50 | -0.38 | -2.3% | $17.20 | $17.20 | $16.44 | 145 | |
| $16.88 | +0.12 | +0.7% | $17.00 | $17.78 | $16.60 | 266 | |
| $16.76 | -0.60 | -3.5% | $17.80 | $17.80 | $16.50 | 418 | |
| $17.36 | +0.68 | +4.1% | $16.76 | $17.40 | $16.76 | 296 | |
| $16.68 | -0.22 | -1.3% | $17.00 | $17.10 | $16.60 | 357 | |
| $16.90 | -0.68 | -3.9% | $17.78 | $17.80 | $16.50 | 584 | |
| $17.58 | -1.22 | -6.5% | $18.60 | $19.54 | $17.26 | 777 | |
| $18.80 | -0.70 | -3.6% | $20.00 | $20.00 | $18.40 | 971 |
Splits
4 splits since 2023 · NASDAQ:HCTI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation | |
| 1-for-60 | Consolidation | |
| 1-for-249 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- NASDAQ:HCTI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Healthcare Triangle Reports Third Quarter 2026 Results: Nine-Month Revenue Up 162% to $28.2 Million and Nine-Month Gross Margin Up 354%
Latest news
Healthcare Triangle Reports Third Quarter 2026 Results: Nine-Month Revenue Up 162% to $28.2 Million and Nine-Month Gross Margin Up 354%
Nov 12, 2026
Closed $3.74 (-14.8%) on Nov 12, 2026
Healthcare Triangle Expands into Indonesia; Identifying USD 45 Million Opportunity
Nov 2, 2026
Closed $4.98 (-3.1%) on Nov 2, 2026
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Oct 26, 2026
Closed $6.84 (+1.8%) on Oct 26, 2026
Three Months In, HCTI's Purpose Health Lands Multiple Wins as AI-Led Momentum Builds
Oct 22, 2026
Closed $7.58 (-8.7%) on Oct 22, 2026
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan
Oct 21, 2026
Closed $7.58 (-8.7%) on Oct 22, 2026
HCTI Expands AI Business with 6 New Contracts, Targeting approx. $4.65M in Annual Run Rate Revenue
Oct 20, 2026
Closed $7.88 (+8.2%) on Oct 20, 2026
Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America
Sep 30, 2026
Closed $14.36 (+8.5%) on Sep 30, 2026
Healthcare Triangle Signs Letter of Intent to Pursue the Proposed Acquisition of Roboticom's Cutting-Edge Industrial Precision Robotics Automation Business
Sep 23, 2026
Closed $18.22 (+5.3%) on Sep 23, 2026
Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies
Sep 17, 2026
Closed $14.20 (+2.9%) on Sep 17, 2026
Healthcare Triangle, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 30 in the last 12 months · 119 in all · newest Nov 12, 2026 · oldest 2021
- Decks
- 4 decks · latest Sep 15, 2025
Where Healthcare Triangle, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HCTI · Home listing · This page | NASDAQ | United States | USD |
| BOATS:HCTI | BOATS | United States | USD |
| Stuttgart:4MR0 | Stuttgart | Germany | EUR |
Valuation
EV/sales 0.6× against a median of 2.2×: 2nd lowest of 9 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $17.54M USD
- P/E
- Loss
- EV/sales
- 0.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.1×
- Gross margin
- 541.8%
- Operating margin
- −45.2%
- Net margin
- −56.4%
- Debt to equity
- 0.3×
- Beta vs S&P 500
- 2.08
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Healthcare Triangle, Inc. · NASDAQ:HCTI | US$2.63M | US$17.54M | n/a | 0.6× | n/a | 0.1× | −56.4% | 0.3× | 2.08 |
| Basel Medical Group Ltd · NASDAQ:BMGL | US$2.91M | US$9.95M | n/a | 0.6× | 1.1× | 0.7× | −3.5% | 1.9× | 0.58 |
| Polomar Health Services, Inc. · OTC:PMHS | US$2.84M | US$2.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.25 |
| Mangoceuticals, Inc. · NASDAQ:MGRX | US$2.75M | US$2.73M | n/a | 9.1× | n/a | 0.3× | n/a | 0.1× | 0.60 |
| UniDoc Health Corp. · CSE:UDOC | US$2.71M | US$2.66M | n/a | 4.0× | n/a | n/a | −327.1% | n/a | -0.61 |
| Modern Mobility Aids, Inc. · OTC:MDRM | US$2.68M | US$2.71M | n/a | n/a | n/a | n/a | n/a | n/a | -0.74 |
| Monsenso A/S · OMXCOP:MONSO | US$2.57M | US$2.69M | n/a | 2.1× | n/a | 2.6× | −81.0% | 0.1× | n/a |
| Visionflex Group Limited · ASX:VFX | US$2.30M | US$1.61M | n/a | 0.6× | n/a | n/a | −1.4% | n/a | n/a |
| Imaging Biometrics Limited · LSE:IBAI | US$2.26M | US$2.43M | n/a | 2.4× | n/a | 5.6× | −50.9% | 0.6× | n/a |
| Feedback plc · LSE:FDBK | US$2.24M | −US$2.77M | n/a | −2.4× | n/a | 0.4× | −826.2% | 0.0× | n/a |
| Predilife SA · EURONEXT:ALPRE | US$2.16M | US$7.61M | n/a | 6.2× | n/a | n/a | −315.3% | n/a | n/a |
| Median of the others | US$2.63M | US$2.67M | 2.2× | 1.1× | 0.7× | −81.0% | 0.1× | 0.25 |
Forecasts
Analysts' consensus from EODHD, read Nov 14, 2026. Not 6ix's view and not investment advice.
- Price target
- 63.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -204.60 · 1 analyst
- Revenue, year to Dec 2026
- 38.84M · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Melissa Hall | Chief Nursing Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 13, 2026 | −11.0% |
| Q2 2026 | Aug 13, 2026 · After close | −30.1% |
| Q1 2026 | Apr 15, 2026 · After close | −3.2% |
| Q3 2025 | Nov 13, 2025 · Before open | −16.1% |
| Q2 2025 | Aug 14, 2025 | +23.1% |
| Q1 2025 | May 20, 2025 | −11.1% |
| Q4 2024 | Mar 31, 2025 | −5.2% |
| Q3 2024 | Nov 29, 2024 | −5.9% |
| Q2 2024 | Aug 7, 2024 | −23.1% |
| Q1 2024 | May 20, 2024 · After close | +9.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 18, 2024 · After close | +4.2% |
| Q3 2023 | Nov 13, 2023 · Before open | 0.0% |
| Q2 2023 | Aug 10, 2023 · After close | 0.0% |
| Q1 2023 | May 9, 2023 · Before open | +3.7% |
| Q4 2022 | Mar 28, 2023 · After close | 0.0% |
| Q3 2022 | Nov 10, 2022 · Before open | −5.1% |
| Q2 2022 | Aug 8, 2022 · Before open | 0.0% |
| Q1 2022 | May 16, 2022 · Before open | 0.0% |
| Q4 2021 | Mar 8, 2022 · After close | 0.0% |
| Quarter to Sep 30, 2021 | Oct 14, 2021 | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2025) | Investor deck | 9 slides | Sep 15, 2025 |
| Investor Presentation (March 2022) | Investor deck | 25 slides | Mar 7, 2022 |
| IPO Roadshow (September 2021) | IPO roadshow | 34 slides | Sep 9, 2021 |
| IPO Roadshow (September 2021) | IPO roadshow | 33 slides | Sep 8, 2021 |
Financings
| Raise | Date |
|---|---|
| 15% original issue discount senior convertible promissory notes Closed: US$3.6M raised · WallachBeth Capital LLC Dealers: WallachBeth Capital LLC (lead) Use of proceeds: Repayment of certain prior indebtedness, potential strategic acquisitions, and general working capital | Jun 12, 2026 |
| Registered direct offering of common stock (or prefunded warrants in lieu thereof) Announced: about US$3.96M · US$5.81 a share · D. Boral Capital, LLC Dealers: D. Boral Capital, LLC (lead) | Feb 26, 2026 |
| Warrant exercise of existing warrants exercised for common stock; new unregistered warrants Announced: about US$478,000 · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital Dealers: WallachBeth Capital | Oct 8, 2025 |
| Warrant exercise of existing warrants exercised for common stock; new unregistered warrants Announced: about US$755,000 · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital Dealers: WallachBeth Capital | Oct 3, 2025 |
| Warrant exercise of existing warrants exercised for common stock; new unregistered warrants Announced: about US$1.63M · US$2 a share · Warrants at US$3 for 60 months · WallachBeth Capital Dealers: WallachBeth Capital (lead) | Oct 2, 2025 |
| Private placement of units of common stock or pre-funded warrants with series A and series B warrants Closed: US$15.2M raised · US$0.42 a unit · Warrants at US$0.84 · RBW Capital, LLC (a division of Dawson James Securities, Inc) +2 Dealers: RBW Capital, LLC (a division of Dawson James Securities, Inc) (co-lead), Spartan Capital Securities, LLC (co-lead), RBW Capital Partners LLC (a division of Dawson James Securities, Inc.) (co-lead) Use of proceeds: Future acquisitions, general corporate purposes and working capital | Feb 28, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$4.00 a share on Oct 12, 2021.
- Price
- US$4.00 a share
- Shares offered
- 4,709,255 shares of common stock · 3,262,500 from the company and 1,446,755 from selling shareholders
- Offering size
- US$18.8 million · Shares offered times the price, worked out by 6ix
- Underwriters' option
- Up to 489,375 more shares
- Listing
- HCTI on the Nasdaq Capital Market
- Underwriter
- EF HUTTON
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 19, 2021 |
| Filed publicly | Aug 30, 2021 |
| Amended 5 times | Newest Oct 8, 2021 |
| Shares registered with an exchange | Oct 12, 2021 |
| Declared effective by the SEC | Oct 12, 2021 |
| Final prospectus, with the price | Oct 14, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 14, 2021 |
| EFFECT · Notice that a registration is effective | Oct 12, 2021 |
| CERT · Exchange's certificate of listing | Oct 12, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 12, 2021 |
| CORRESP · Letter to the SEC | Oct 8, 2021 |
| CORRESP · Letter to the SEC | Oct 8, 2021 |
| S-1/A · Registration statement, amended | Oct 8, 2021 |
| S-1/A · Registration statement, amended | Oct 7, 2021 |
| CORRESP · Letter to the SEC | Oct 6, 2021 |
| CORRESP · Letter to the SEC | Oct 6, 2021 |
All 31 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Oct 4, 2021 |
| CORRESP · Letter to the SEC | Oct 4, 2021 |
| S-1/A · Registration statement, amended | Sep 30, 2021 |
| S-1/A · Registration statement, amended | Sep 27, 2021 |
| CORRESP · Letter to the SEC | Sep 17, 2021 |
| UPLOAD · Letter from the SEC | Sep 15, 2021 |
| CORRESP · Letter to the SEC | Sep 10, 2021 |
| S-1/A · Registration statement, amended | Sep 10, 2021 |
| UPLOAD · Letter from the SEC | Sep 9, 2021 |
| FWP · Free writing prospectus | Sep 9, 2021 |
| CORRESP · Letter to the SEC | Aug 30, 2021 |
| CORRESP · Letter to the SEC | Aug 30, 2021 |
| S-1 · Registration statement | Aug 30, 2021 |
| UPLOAD · Letter from the SEC | Aug 11, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jul 23, 2021 |
| DRS/A · Draft registration statement, amended | Jul 23, 2021 |
| UPLOAD · Letter from the SEC | Jul 13, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jun 24, 2021 |
| DRS/A · Draft registration statement, amended | Jun 24, 2021 |
| UPLOAD · Letter from the SEC | May 18, 2021 |
| DRS · Draft registration statement | Apr 19, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Oct 14, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.9M | 11.7M | 33.2M | 45.9M | 35.3M | 31.3M | 28.7M | 232.4K | 5.82K | 29.4K |
| Cost of revenue | 12.0M | 8.81M | 26.4M | 34.6M | 24.7M | 22.8M | 23.7M | 134.3K | 4.61K | 1.99K |
| Gross profit | 1.24B | 1.07B | 1.07B | 11.3M | 10.5M | 7.78M | 5.07M | 98.0K | 1.21K | 27.4K |
| Research and development | 536.0K | 429.0K | 799.0K | 8.14M | 5.26M | 1.74M | 1.01M | 0 | 0 | 0 |
| Selling, general and administrative | 7.34M | 3.95M | 5.73M | 0 | 0 | 2.44M | 1.70M | 1.07M | 1.87M | 2.95M |
| Operating income | -9.79M | -4.75M | -7.70M | -16.3M | -5.36M | 1.18M | 1.67M | -1.29M | -2.98M | -3.73M |
| Depreciation and amortization | 705.0K | 889.0K | 1.57M | 2.94M | 1.42M | 803.2K | 776.1K | 705.5K | 1.11M | 808.7K |
| EBITDA | -9.08M | -3.86M | -6.13M | -13.4M | -3.94M | 1.98M | 2.45M | -583.0K | -1.87M | -2.92M |
| Interest expense | 567.0K | 1.21M | 968.0K | 212.0K | 567.0K | 78.6K | 52.6K | 0 | 0 | 0 |
| Income before tax | -9.48M | -5.96M | -8.65M | -13.9M | -5.92M | 2.61M | 1.62M | -4.58M | -6.73M | -5.83M |
| Income tax | 12.0K | 35.0K | 506.0K | 24.0K | 257.4K | 444.4K | 0 | 0 | 0 | |
| Net income | -9.48M | -5.97M | -8.69M | -14.4M | -5.95M | 2.35M | 1.17M | -4.58M | -6.73M | -5.83M |
| Earnings per share, basic | -152.30 | -16,909.30 | -2.08 | -3.88 | -0.20 | 0.08 | -323.99 | -476.38 | -412.90 | |
| Earnings per share, diluted | -152.30 | -16,909.30 | -2.08 | -3.88 | -0.20 | 0.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.63M | 20.0K | 1.23M | 1.34M | 1.77M | 1.40M | 974.8K | 28 | 23.9K | 0 |
| Short-term investments | 0 | 0 | 0 | |||||||
| Receivables | 2.07M | 1.11M | 3.60M | 5.87M | 9.67M | 6.40M | 4.17M | |||
| Inventory | 1 | 1 | 0 | 0 | 0 | |||||
| Current assets | 13.2M | 1.45M | 5.65M | 8.02M | 11.8M | 8.03M | 5.29M | 28 | 23.9K | 0 |
| Property, plant and equipment | 5.00K | 12.0K | 44.0K | 80.0K | 74.0K | 15.8K | 41.6K | 0 | 0 | 0 |
| Goodwill | 2.95M | 0 | 1.29M | 1.29M | 1.29M | 0 | 0 | 0 | 0 | |
| Total assets | 22.7M | 1.96M | 6.86M | 13.3M | 24.6M | 11.1M | 8.25M | 2.12M | 1.17M | 2.14M |
| Accounts payable | 744.0K | 2.54M | 1.95M | 1.48M | 1.87M | 4.35M | 5.10M | 1.17M | 866.1K | 667.3K |
| Current liabilities | 12.8M | 7.08M | 8.15M | 6.60M | 6.25M | 6.78M | 6.20M | 9.88M | 6.49M | 6.19M |
| Long-term debt | 888.0K | 0 | 1.34M | 1.34M | ||||||
| Total debt | 10.7M | 2.65M | 4.68M | 2.69M | 3.45M | 754.4K | ||||
| Total liabilities | 12.8M | 7.08M | 8.25M | 7.22M | 8.48M | 6.78M | 6.28M | 9.88M | 7.83M | 7.71M |
| Shareholders' equity | 9.98M | -5.11M | 538.0K | 6.04M | 14.2M | 4.33M | 1.97M | -7.75M | -6.66M | -5.58M |
| Shares outstanding | 7.12K | 380 | 4.31M | 4.17M | 35.3M | 27.9M | 12 | 14.1K | 14.1K | 14.1K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -16.5M | -1.08M | -2.15M | -5.35M | -7.11M | -734.7K | 3.97M | -971.3K | -513.6K | -394.1K |
| Capital spending | -6.00K | -13.0K | -12.0K | -40.0K | -3.13M | -3 | -3.65M | -5.00K | 0 | 0 |
| Free cash flow | -16.5M | -1.08M | -2.16M | -5.39M | -10.2M | -734.7K | 3.97M | -976.3K | -513.6K | -394.1K |
| Cash from investing | -1.75M | -13.0K | -12.0K | -1.13M | -7.63M | -477.5K | -3.65M | -5.00K | -12.0K | -12.0K |
| Cash from financing | 25.9M | -133.0K | 2.06M | 6.06M | 15.1M | 1.64M | 1.64M | 952.5K | 549.5K | 394.1K |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | |||||
| Share buybacks | -142.0K | -141.0K | 0 | 696 | 696 | |||||
| Change in cash | 7.61M | -1.21M | -107.0K | -429.0K | 367.0K | 427.9K | 974.8K | -23.9K | 23.9K | 23.9K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Oct 27, 2026 | Current report | SEC |
| 8-K · Current report | Oct 23, 2026 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Oct 13, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 2, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 2, 2026 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Oct 1, 2026 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Sep 25, 2026 | Offer document | SEC |
| 8-K · Current report | Sep 25, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 8, 2026 | Material contract | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 29, 2026 | Financing | SEC |
| 8-K · Current report | Jul 20, 2026 | Meeting outcome | SEC |
| 424B3 · Prospectus | Jul 16, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 16, 2026 | Other filings | SEC |
| S-1 · Registration statement | Jul 10, 2026 | Offer document | SEC |
| RW · Request to withdraw a registration | Jul 9, 2026 | Other filings | SEC |
| S-3 · Registration statement | Jul 6, 2026 | Offer document | SEC |
| DEF 14A · Proxy statement | Jun 26, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jun 26, 2026 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Jun 16, 2026 | Meeting notice | SEC |
| D | Jun 16, 2026 | Other filings | SEC |
| 8-K · Current report | Jun 15, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Apr 16, 2026 | Annual report | SEC |
| 10-K · Annual report | Apr 15, 2026 | Annual report | SEC |
| 8-K · Current report | Apr 10, 2026 | Material contract | SEC |
| 8-K/A · Current report, amended | Apr 7, 2026 | Current report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 424B5 · Prospectus | Mar 31, 2026 | Offer document | SEC |
| 8-K · Current report | Mar 11, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 5, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Mar 2, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 27, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Feb 27, 2026 | Offer document | SEC |
| 8-K · Current report | Feb 13, 2026 | Current report | SEC |
| 8-K · Current report | Feb 6, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Jan 28, 2026 | Acquisition or disposal | SEC |
| DEF 14A · Proxy statement | Jan 20, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jan 9, 2026 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Dec 22, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 16, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Dec 15, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Dec 10, 2025 | Material contract | SEC |
| D | Dec 3, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 2, 2025 | Meeting outcome | SEC |
| S-3 · Registration statement | Nov 28, 2025 | Offer document | SEC |
| 424B3 · Prospectus | Nov 25, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Nov 25, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 21, 2025 | Material contract | SEC |
| CORRESP · Letter to the SEC | Nov 20, 2025 | Other filings | SEC |
| S-3/A · Registration statement, amended | Nov 19, 2025 | Offer document | SEC |
| 8-K · Current report | Nov 19, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Nov 19, 2025 | Offer document | SEC |
| DEF 14A · Proxy statement | Nov 18, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2025 | Meeting outcome | SEC |
| PRE 14A · Preliminary proxy statement | Nov 7, 2025 | Meeting notice | SEC |
| S-3 · Registration statement | Oct 16, 2025 | Offer document | SEC |
| DEF 14A · Proxy statement | Oct 15, 2025 | Meeting notice | SEC |
| DEF 14C | Oct 14, 2025 | Meeting notice | SEC |
| 8-K · Current report | Oct 8, 2025 | Material contract | SEC |
| PRE 14C | Oct 2, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 30, 2025 | Meeting notice | SEC |
| 8-K · Current report | Sep 15, 2025 | Current report | SEC |
| 8-K/A · Current report, amended | Aug 29, 2025 | Material contract | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 1, 2025 | Current report | SEC |
| 8-K · Current report | Jul 7, 2025 | Current report | SEC |
| 8-K · Current report | Jun 23, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | May 30, 2025 | Current report | SEC |
| 8-K · Current report | May 23, 2025 | Current report | SEC |
| 10-Q · Quarterly report | May 20, 2025 | Quarterly report | SEC |
| 424B4 · Prospectus | May 15, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 15, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 13, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 13, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 13, 2025 | Other filings | SEC |
| NT 10-Q · Late filing notice | May 9, 2025 | Explanation request | SEC |
| CORRESP · Letter to the SEC | May 8, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 8, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 5, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Apr 22, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Apr 22, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 15, 2025 | Other filings | SEC |
| 8-K · Current report | Apr 11, 2025 | Current report | SEC |
| 8-K · Current report | Apr 11, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 2, 2025 | Meeting outcome | SEC |
| S-1 · Registration statement | Apr 2, 2025 | Offer document | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 24, 2025 | Management or board change | SEC |
| DEF 14C | Mar 17, 2025 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Mar 7, 2025 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Mar 7, 2025 | Meeting notice | SEC |
| PRE 14C | Mar 5, 2025 | Meeting notice | SEC |
| 8-K · Current report | Feb 28, 2025 | Material contract | SEC |
| 8-K · Current report | Feb 26, 2025 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Feb 25, 2025 | Meeting notice | SEC |
| 10-K/A · Annual report, amended | Feb 14, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 14, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 4, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jan 21, 2025 | Current report | SEC |
| 8-K · Current report | Dec 4, 2024 | Current report | SEC |
| 8-K/A · Current report, amended | Dec 2, 2024 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 25, 2024 | Material contract | SEC |
| 8-K · Current report | Sep 10, 2024 | Management or board change | SEC |
| 8-K · Current report | Sep 6, 2024 | Current report | SEC |
| PRE 14C | Aug 30, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 19, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 15, 2024 | Explanation request | SEC |
| 8-K · Current report | Jun 27, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 20, 2024 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 16, 2024 | Explanation request | SEC |
| 8-K · Current report | May 13, 2024 | Current report | SEC |
| 8-K · Current report | May 6, 2024 | Current report | SEC |
| 8-K · Current report | Mar 22, 2024 | Current report | SEC |
| 10-K · Annual report | Mar 18, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 18, 2024 | Management or board change | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Mar 13, 2024 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Feb 14, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 12, 2024 | Offer document | SEC |
| S-1/A · Registration statement, amended | Feb 9, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 9, 2024 | Other filings | SEC |
| 8-K · Current report | Feb 2, 2024 | Current report | SEC |
| 8-K · Current report | Feb 1, 2024 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Feb 1, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 29, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 26, 2024 | Other filings | SEC |
| DEF 14C | Jan 19, 2024 | Meeting notice | SEC |
| S-3/A · Registration statement, amended | Jan 16, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jan 16, 2024 | Other filings | SEC |
| S-1 · Registration statement | Jan 12, 2024 | Offer document | SEC |
| 8-K/A · Current report, amended | Jan 12, 2024 | Material contract | SEC |
| PRE 14C | Jan 9, 2024 | Meeting notice | SEC |
| S-3 · Registration statement | Jan 4, 2024 | Offer document | SEC |
| 10-K/A · Annual report, amended | Jan 4, 2024 | Annual report | SEC |
| 8-K · Current report | Jan 2, 2024 | Material contract | SEC |
| 8-K · Current report | Nov 29, 2023 | Management or board change | SEC |
| DEFR14A | Nov 16, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Nov 9, 2023 | Meeting notice | SEC |
| 8-K · Current report | Sep 5, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 14, 2023 | Management or board change | SEC |
| 8-K · Current report | Jun 29, 2023 | Current report | SEC |
| 8-K · Current report | Jun 5, 2023 | Current report | SEC |
| 8-K · Current report | May 30, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 4, 2023 | Management or board change | SEC |
| 8-K · Current report | Apr 6, 2023 | Material contract | SEC |
| 10-K · Annual report | Mar 28, 2023 | Annual report | SEC |
| 4 · Change in ownership | Mar 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 6, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 6, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 6, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 30, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 27, 2023 | Management or board change | SEC |
| 8-K · Current report | Dec 30, 2022 | Current report | SEC |
| 8-K · Current report | Dec 23, 2022 | Management or board change | SEC |
| 8-K · Current report | Nov 21, 2022 | Meeting outcome | SEC |
| 4/A · Change in ownership, amended | Nov 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 10, 2022 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Oct 19, 2022 | Annual report | SEC |
| DEF 14A · Proxy statement | Oct 19, 2022 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 3, 2022 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Aug 23, 2022 | Other filings | SEC |
| 4 · Change in ownership | Aug 22, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Aug 22, 2022 | Insider trade | SEC |
| CORRESP · Letter to the SEC | Aug 18, 2022 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 18, 2022 | Offer document | SEC |
| S-1 · Registration statement | Aug 18, 2022 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Aug 15, 2022 | Other filings | SEC |
| DRS · Draft registration statement | Aug 9, 2022 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 8, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jul 13, 2022 | Material contract | SEC |
| 8-K · Current report | Jun 10, 2022 | Current report | SEC |
| 8-K · Current report | May 27, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 8-K · Current report | Apr 1, 2022 | Material contract | SEC |
| 3 · Initial statement of ownership | Apr 1, 2022 | Insider trade | SEC |
| 10-K · Annual report | Mar 8, 2022 | Annual report | SEC |
| 8-K/A · Current report, amended | Feb 23, 2022 | Current report | SEC |
| 5 · Annual statement of ownership | Feb 14, 2022 | Insider trade | SEC |
This page holds 200 of 264 filings. Open Filings
Cap table
Built by 6ix from Healthcare Triangle, Inc.’s releases · as of Nov 11, 2026
- Common shares
- 915,189
- Fully diluted
- 37,105,674
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 915,189 | Nov 11, 2026 |
| Warrants | 36,190,485 | Feb 28, 2025 |
Warrants and options
| Lot |
|---|
| Warrants · US$0.84 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 11, 2026 | 915,189 |
| Oct 22, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jeffrey S Mathiesen Other companies: Solana Company (CFO and Treasurer, Director · Since at least Jun 10, 2020); NeuroOne Medical Technologies Corporation (Director · Since at least Aug 4, 2017); Panbela Therapeutics, Inc. (Director · Dec 1, 2020 – Mar 27, 2023 · Past); MetaVia Inc. (Chief Financial Officer · Aug 4, 2016 – Jan 28, 2018 · Past); Nuwellis, Inc. (Chief Financial Officer · Feb 14, 2012 – Jan 1, 2015 · Past); Zareba Systems Inc (Chief Financial Officer · Jun 30, 2008 – Jun 30, 2009 · Past) | Director · Mar 31, 2022 – Aug 19, 2022 · Past |
| Dave Rosa Other companies: BioRestorative Therapies, Inc. (President & CEO at NeuroOne Medical Technologies Corp. (NASDAQ: NMTC) · Since at least Nov 4, 2021); NeuroOne Medical Technologies Corporation (CEO & President, Director · Since at least Jul 20, 2017); Biotricity, Inc. (Director · Jul 16, 2019 – Mar 12, 2023 · Past); Nuwellis, Inc. (Chief Executive Officer, Director · Feb 14, 2012 – Aug 1, 2015 · Past) | Director · Oct 15, 2021 – Mar 12, 2024 · Past |
| Ronald W McClurg Other companies: Biotricity, Inc. (Director · May 4, 2022 – May 4, 2022 · Past); NeuroOne Medical Technologies Corporation (Chief Financial Officer · Jan 1, 2021 – Apr 17, 2025 · Past) | Director · Jan 27, 2023 – Mar 12, 2024 · Past |
| April Bjornstad | Director · Oct 15, 2021 – Aug 19, 2022 · Past |
| Brendan Gallagher | Director · Oct 15, 2021 – Dec 31, 2021 · Past |
| Lakshmanan Kannappan | Business Head · Mar 20, 2023 – Mar 31, 2025 · Past |
| Mogli Sudish | Chief Technology Officer · Oct 15, 2021 – Dec 31, 2021 · Past |
| Mohammad Jainal Bhuiyan | Director · Jan 27, 2023 – Mar 12, 2024 · Past |
| Paige Heaphy | Director · Jan 27, 2023 – Jan 27, 2023 · Past |
| Roy Sookhoo | Director · Jan 27, 2023 – Jan 27, 2023 · Past |
All 14 people
| Person | Seat |
|---|---|
| Shibu Kizhakevilayil | Head of M&A, Director · Oct 15, 2021 – Mar 31, 2025 · Past |
| Sumit Ganguli | Chairman and Chief Executive Officer of Purpose Health, Inc · Jul 27, 2026 – Nov 5, 2026 · Past |
| Thyagarajan Ramachandran | Chief Financial Officer · Oct 15, 2021 – Mar 31, 2025 · Past |
| Vivek Prakash | Director · Oct 15, 2021 – Dec 31, 2021 · Past |
Log in to ask 6ix AI your own questions about Healthcare Triangle, Inc.